Joao Pinto

Dr. Joao Pinto

iMed.ULisboa, Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Powder Technology
Verified
Journal Article
Closed access
JVJoão Vicente
João Vicente
JPJoao Pinto
Joao Pinto
JMJosé Menezes
José Menezes
FGFilipe Gaspar
Filipe Gaspar

1 August 2010 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JPJoao Pinto
Joao Pinto

22 August 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GPGabriela G. Pereira
Gabriela G. Pereira
SFSara Figueiredo
Sara Figueiredo
Ana Isabel FernandesAna Isabel Fernandes
Ana Isabel Fernandes
JPJoao Pinto
Joao Pinto
Three-dimensional (3D) printing offers the greatest potential to revolutionize the future of pharmaceutical manufacturing by overcoming challenges of conventional pharmaceutical operations and focusing design and production of dosage forms on the patient’s needs. Of the many technologies available, fusion deposition modelling (FDM) is considered of the lowest cost and higher reproducibility and accessibility, offering clear advantages in drug delivery. FDM requires in-house production of filaments of drug-containing thermoplastic polymers by hot-melt extrusion (HME), and the prospect of connecting the two technologies has been under investigation. The ability to integrate HME and FDM and predict and tailor the filaments’ properties will extend the range of printable polymers/formulations. Hence, this work revises the properties of the most common pharmaceutical-grade polymers used and their effect on extrudability, printability, and printing outcome, providing suitable processing windows for different raw materials. As a result, formulation selection will be more straightforward (considering the characteristics of drug and desired dosage form or release profile) and the processes setup will be more expedite (avoiding or mitigating typical processing issues), thus guaranteeing the success of both HME and FDM. Relevant techniques used to characterize filaments and 3D-printed dosage forms as an essential component for the evaluation of the quality output are also presented.

1 July 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
EZEva Zupančič
Eva Zupančič
CCCaterina Curato
Caterina Curato
MPMaria Paisana
Maria Paisana
Cecilia MP RodrigugesCecilia MP Rodriguges
Cecilia MP Rodriguges
Ziv PoratZiv Porat
Ziv Porat
HFHelena Florindo
Helena Florindo

1 February 2009 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
PSPaulo José Salústio
Paulo José Salústio
GFG. Feio
G. Feio
JFJoão Figueirinhas
João Figueirinhas
JPJoao Pinto
Joao Pinto
HCHelena Cabral-Marques
Helena Cabral-Marques

11 January 2018 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
MFMónica P. A. Ferreira
Mónica P. A. Ferreira
VTVirpi Talman
Virpi Talman
GTGiulia Torrieri
Giulia Torrieri
DLDongfei Liu
Dongfei Liu
GMGonçalo Marques
Gonçalo Marques
Hélder SantosHélder Santos
Hélder Santos